+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Expired

Warren Alpert Foundation Prize

Harvard Medical School

The prize was established in 1987 by the late philanthropist and businessman, Warren Alpert and the Warren Alpert Foundation. The Warren Alpert Prize is given internationally and since its inception, sixteen Nobel Prize winners have received the award. The prize is administered in concert with Harvard Medical School in Boston, Massachusetts and the Warren Alpert Foundation, located in Providence, Rhode Island. An annual scientific symposium is held at Harvard Medical School each fall in honor of the recipient(s).

Prize Value

The value of the prize is U.S. $500,000 (to be split equally if more than one recipient is selected). A special scientific symposium in honor of the recipient(s) is held each October at Harvard Medical School.

Selection Process

Prize recipients are selected by the Foundation's Scientific Advisory Committee, comprising internationally renowned biomedical scientists and chaired by the Dean of Harvard Medical School.

AI Based Application Success Predictor

Predictor	Why It Matters	Evidence / Pattern from Laureates
Transformative biomedical discovery	The prize consistently honors breakthroughs that redefine a disease field or create a new therapeutic class.	Gene therapy, immune modulation, molecular biology, and AI biology dominate.
Clear, demonstrable clinical impact	Discoveries must have led to — or soon lead to — a tangible improvement in patient outcomes.	All laureates’ work translated to licensed drugs, diagnostics, or technologies.
High scientific originality and innovation	Paradigm-shifting work (not incremental).	Typically the “first” or “foundational” discovery in its category.
Sustained contribution and validation	Work must withstand peer validation over several years.	Recognition often comes 5–15 years post-discovery.
Global scientific influence	Widespread adoption and citation across disciplines.	Many laureates have >50,000 citations and global collaborations.
Ethical and societal benefit	Advances improving public health globally are favored.	e.g., malaria cure, vaccines, immunotherapies.
Collaborative, cross-disciplinary discovery	Often shared among 2–5 scientists across complementary disciplines.	Reflects team science model.
Peer nomination by leading institutions	Nominations are submitted by top-tier universities and scientific societies.	Harvard, NIH, Max Planck, and Oxford are frequent nominators.

🧩 Common Traits of Awarded Discoveries

Category	Examples of Recognized Contributions
Immunology & Cancer	Immune checkpoints, CAR-T therapy, cytokine signaling.
Molecular Biology / Genetics	CRISPR, RNA biology, autoinflammatory disease mechanisms.
Infectious Diseases	Hepatitis C, malaria, mRNA vaccines.
Neuroscience	Pain receptors, synaptic signaling.
AI & Computational Biology	AlphaFold protein structure prediction.

👩‍🔬 Profile of Typical Laureates

Attribute	Pattern Among Awardees
Position	Senior investigators or laboratory heads (≥15 years research leadership).
Institutional Affiliation	Prestigious universities (Harvard, MIT, Stanford, NIH, Oxford, Max Planck, Weizmann, Kyoto).
Publication Record	100–500 papers; multiple Science, Nature, Cell, NEJM articles.
Impact Metrics	Citation index >30,000; h-index >80.
Funding History	NIH, Wellcome, ERC, HHMI, or similar.
Prior Awards	Lasker, Gairdner, Breakthrough Prize, or early field recognition.

🧠 Strategic Insights for Nominators

Nominees should have a clearly documented discovery trajectory — from fundamental insight → clinical application → population health benefit.

Provide specific evidence (publications, clinical trial outcomes, adoption metrics).

Demonstrate broad scientific consensus on the discovery’s transformative nature.

Highlight collaborative or translational breakthroughs, not isolated lab findings.

Strong letters from distinguished nominators (Nobelists, academy members) increase credibility.

⚖️ Notable Characteristics of the Selection Process

Nominations are evaluated by a Harvard Medical School scientific committee.

Judging emphasizes scientific excellence, originality, and health impact, not seniority or nationality.

Awards are occasionally shared among contributors to a single discovery.

Ceremony and scientific symposium held annually at Harvard Medical School, with global dissemination.

🏆 Summary: Success Predictors for the Warren Alpert Foundation Prize

Transformative biomedical discovery (not incremental).

Demonstrated clinical or global health impact.

Scientific originality and paradigm shift.

Sustained validation and broad adoption.

Collaborative, multidisciplinary contribution.

Endorsement by peers and institutions of global stature.

Alignment with human health improvement — prevention, diagnosis, or therapy.

Specialties

Others

Public Health

Eligibility Requirements

Self nominations are not accepted.
Nominees must be living.
Multiple nominations from an institution are permitted.
Nominees cannot have received a Nobel Prize for the same discovery for which they are being nominated.

Criteria

Up to five nominees may be co-nominated in one nomination.
Nominations are submitted online. Nomination portal
The online nomination form for the Prize must include the following information:
- Contact information for the nominee(s) and nominator.
- Description of the nominee's research as it relates to the nomination. Include the top five bibliographical references related to the nomination.
- A suggested citation or reason for the award (maximum fifty words).
- Brief explanation of why you are nominating this person or group over others who have made significant contributions in the same area of research.
- If nominating an individual, comment on whether it is appropriate to share this prize. If so, please describe their contributions
- Two letters of support.
- CV of the nominee(s).

Sponsor Details

Sponsor Institute/Organizations: Harvard Medical School

Sponsor Type: Corporate/Non-Profit

Address: 25 Shattuck Street Boston, MA 02115

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity